The European Registry for Patients with Mechanical Circulatory Support (EUROMACS): third Paediatric (Paedi-EUROMACS) report.
Theo M M H de ByMartin SchweigerHina HussainAntonio AmodeoThomas MartensAd J J C BogersKevin DammanCan Gollmann-TepeköylüMichael HulmanAttilio IacovoniUlrike M KrämerAntonino LoforteCarlo Pace NapoleonePetr NěmecIvan NetukaMustafa ÖzbaranLuz PoloYuri PyaFaiz RamjankhanEugen SandicaJoanna ŚliwkaBrigitte StillerAlexander KadnerAlessio FranceschiniTimothy ThiruchelvamDaniel ZimpferBart MeynsFelix BergerOliver MieraPublished in: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2022)
The overall survival rate was 79.2% at 12 months following ventricular assist device implant. The comparison of survival rates of the early and later eras shows no significant difference. A focus on specific subgroups showed that survival was less in patients of younger age (<1 year of age; P = 0.01) and lower weight (<20 kg; P = 0.015). Transplant rates at 6 months continue to be low (33.2%).
Keyphrases
- end stage renal disease
- free survival
- ejection fraction
- newly diagnosed
- chronic kidney disease
- heart failure
- emergency department
- intensive care unit
- body mass index
- peritoneal dialysis
- prognostic factors
- physical activity
- left ventricular
- extracorporeal membrane oxygenation
- soft tissue
- patient reported outcomes
- catheter ablation